IBB icon

iShares Biotechnology ETF

649 hedge funds and large institutions have $4.6B invested in iShares Biotechnology ETF in 2018 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 154 increasing their positions, 253 reducing their positions, and 83 closing their positions.

Holders
649
Holders Change
+18
Holders Change %
+2.85%
% of All Funds
14.48%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.4%
New
112
Increased
154
Reduced
253
Closed
83
Calls
$321M
Puts
$610M
Net Calls
-$289M
Net Calls Change
-$13.4M
Name Market Value Shares Shares
Change
Shares
Change %
PCA
726
Providence Capital Advisors
North Carolina
-175 Closed
CAG
727
Csenge Advisory Group
Florida
-120 Closed
BA
728
Ballew Advisors
Mississippi
-107 Closed
CGT
729
Capital Guardian Trust
California
-75 Closed
ATC
730
Adirondack Trust Company
New York
-45 Closed
SWMG
731
Signature Wealth Management Group
Georgia
-30 Closed
ML
732
McAdam LLC
Pennsylvania
-21 Closed
DWM
733
Destination Wealth Management
California
-1 Closed
SCM
734
Segantii Capital Management
Hong Kong
QAM
735
QCI Asset Management
New York
$0 3
LWA
736
Lenox Wealth Advisors
New York
$0 3
Twin Tree Management
737
Twin Tree Management
Texas
CA
738
Continental Advisors
Utah
MG
739
Meritage Group
California
CAM
740
CenterStar Asset Management
Illinois
SPM
741
Symmetry Peak Management
Pennsylvania
Capstone Investment Advisors
742
Capstone Investment Advisors
New York
NCM
743
Nantahala Capital Management
Connecticut
Capital Fund Management (CFM)
744
Capital Fund Management (CFM)
France
HCM
745
Highbridge Capital Management
New York
FIA
746
FNY Investment Advisers
New York